Risk factors for AA amyloidosis in Germany

References

• Hazenberg BP. Amyloidosis: a clinical overview. Rheum Dis Clin North Am 2013;39:323–45
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, Ikeda SI, Merlini G, Saraiva MJ, Westermark P. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 2014;21:221--4
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879–85
   PubMed Web of Science ®Google Scholar
• Pras E, Livneh A, Balow JE, Jr Kastner DL, Pras M, Langevitz P. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998;75:216–19
   PubMed Web of Science ®Google Scholar
• Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 2005;84:1–11
   PubMed Web of Science ®Google Scholar
• Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000;67:1136–43
   PubMed Web of Science ®Google Scholar
• Kukuy O, Livneh A, Ben-David A, Kopolovic J, Volkov A, Shinar Y, Holtzman E, et al. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients. J Rheumatol 2013;40:2083–7
   PubMedGoogle Scholar
• Cazeneuve C, Sarkisian T, Pêcheux C, Dervichian M, Nédelec B, Reinert P, Ayvazyan A, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999;65:88–97
   PubMed Web of Science ®Google Scholar
• Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalçinkaya F, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007;56:1706–12
   PubMed Web of Science ®Google Scholar
• Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009;68:246–8
   PubMed Web of Science ®Google Scholar
• Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:1001–5
   PubMed Web of Science ®Google Scholar
• Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998;5:262–5
   PubMed Web of Science ®Google Scholar
• Bakkaloglu A, Duzova A, Ozen S, Balci B, Besbas N, Topaloglu R, Ozaltin F, et al. Influence of serum amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population. J Rheumatol 2004;31:1139–42
   PubMed Web of Science ®Google Scholar
• Delibaş A, Oner A, Balci B, Demircin G, Bulbul M, Bek K, Erdoğan O, et al. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am J Nephrol 2005;25:434–40
   PubMedGoogle Scholar
• Utku U, Dilek M, Akpolat I, Bedir A, Akpolat T. SAA1 alpha/alpha alleles in Behçet's disease related amyloidosis. Clin Rheumatol 2007;26:927–9
   PubMed Web of Science ®Google Scholar
• van der Hilst JC, Drenth JP, Bodar EJ, Bijzet J, van der Meer JW, Simon A; International HIDS Study Group. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid 2005;12:115–19
   PubMed Web of Science ®Google Scholar
• Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003;48:1149–55
   PubMed Web of Science ®Google Scholar
• Müller D, Roessner A, Röcken C. Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and alpha 2-macroglobulin in cases of generalized AA- and AL amyloidosis. Virchows Arch 2000;437:521–7
   PubMed Web of Science ®Google Scholar
• van der Hilst JC, Yamada T, Op den Camp HJ, van der Meer JW, Drenth JP, Simon A. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis. Rheumatology 2008;47:1651–4
   PubMed Web of Science ®Google Scholar
• Ebrahimi-Fakhari D, Schönland SO, Hegenbart U, Lohse P, Beimler J, Wahlster L, Ho AD, et al. Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk. Scand J Rheumatol 2013;42:52–8
   PubMed Web of Science ®Google Scholar
• Okuda Y, Yamada T, Matsuura M, Takasugi K, Goto M. Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis. Amyloid 2011;18:108–11
   PubMed Web of Science ®Google Scholar
• Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology 2006;45:43–9
   PubMed Web of Science ®Google Scholar
• Hazenberg BPC. Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis. Amyloid 2012;19:56–7
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361–71
   PubMed Web of Science ®Google Scholar
• Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, Crowson CS, et al. Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk. J Rheumatol 2009;36:2290–7
   PubMedGoogle Scholar
• Marie I, Proux A, Duhaut P, Primard E, Lahaxe L, Girszyn N, Louvel JP, et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine 2009;88:182–92
   PubMedGoogle Scholar
• Brambilla F, Lavatelli F, Merlini G, Mauri P. Clinical proteomics for diagnosis and typing of systemic amyloidoses. Proteomics Clin Appl 2013;7:136–43
   PubMed Web of Science ®Google Scholar
• Fisher BA, Lachmann HJ, Rowczenio D, Goodman HJ, Bhalara S, Hawkins PN. Colchicine responsive periodic fever syndrome associated with pyrin I591T. Ann Rheum Dis 2005;64:1384–5
   PubMedGoogle Scholar
• Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L, Frenkel J, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/ EURO-TRAPS international registry. Ann Rheum Dis 2014;73:2160-7
   PubMed Web of Science ®Google Scholar
• Vitale A, Lucherini OM, Galeazzi M, Frediani B, Cantarini L. Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol 2012;30:943–6
   PubMedGoogle Scholar
• Koivuniemi R, Paimela L, Suomalainen R, Tornroth T, Leirisalo-Repo M. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 2008;15:262–8
   PubMed Web of Science ®Google Scholar